Cargando…
Development of gold nanoparticle-based biosensors for COVID-19 diagnosis
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative organism of coronavirus disease 2019 (COVID-19) which poses a significant threat to public health worldwide. Though there are certain recommended drugs that can cure COVID-19, their therapeutic efficacy is limi...
Autores principales: | Khan, Johra, Rasmi, Yousef, Kırboğa, Kevser Kübra, Ali, Ahmad, Rudrapal, Mithun, Patekar, Rohan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444098/ https://www.ncbi.nlm.nih.gov/pubmed/36092513 http://dx.doi.org/10.1186/s43088-022-00293-1 |
Ejemplares similares
-
Emerging point-of-care biosensors for rapid diagnosis of COVID-19: current progress, challenges, and future prospects
por: Rasmi, Yousef, et al.
Publicado: (2021) -
The importance of neopterin in COVID-19: The prognostic value and relation with the disease severity
por: Rasmi, Yousef, et al.
Publicado: (2022) -
Identifying Cardiovascular Disease Risk Factors in Adults with Explainable Artificial Intelligence
por: Kübra Kırboğa, Kevser, et al.
Publicado: (2023) -
Evolution of RNA viruses from SARS to SARS-CoV-2 and diagnostic techniques for COVID-19: a review
por: Khan, Johra, et al.
Publicado: (2021) -
Perspective Insights to Bio-Nanomaterials for the Treatment of Neurological Disorders
por: Khan, Johra, et al.
Publicado: (2021)